期刊文献+

慢性阻塞性肺疾病急性加重期多器官功能衰竭的危险因素分析 被引量:21

Analysis on the risk factors for multiple organ dysfunction syndrome in acute exacerbation of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的分析慢性阻塞性肺疾病急性加重期多器官功能衰竭的危险因素。方法选择2004年1月至2009年11月住院的114例慢性阻塞性肺疾病急性加重期患者,按是否并发多器官功能衰竭分为两组:观察组为41例慢性阻塞性肺疾病急性加重期继发多器官功能衰竭的患者,对照组为73例为未发生多器官功能衰竭的慢性阻塞性肺疾病急性加重期患者。观察和对照采用统一的调查表,对研究资料先进行单因素分析,然后进行多因素非条件Logistic回归模型分析。结果经分析筛选出慢性阻塞性肺疾病的病程(OR=12.480)、COPD的治疗时机(OR=1.324)、有创通气(OR=11.055)、肺炎(OR=8.667)、持续发热(OR=3.836)这5个因素为慢性阻塞性肺疾病急性加重期伴多器官功能衰竭的独立危险因素。结论慢性阻塞性肺疾病急性加重期伴多器官功能衰竭与病程、有创通气关系最为密切,持续发热也可促发MODS。 Objective To explore risk factors for multiple organ dysfunction syndrome (MODS) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) with. Methods A total of 114 patients suffering from acute exacerbation of COPD hospitalized in the Department of Respiratory Medicine from January 2004 to November 2009 were divided into two groups: the study group (n=41, combined with MODS ) and the control group (n=73 without MODS). Patients in the two groups were investigated by self-designed questionnaire, descriptive statistics, chi-square tests. Multivariate logistic regression were used to for statistical analysis. Results The duration of COPD (OR=12.480), timing of treatment of COPD (OR=1.324), invasive mechanical ventilation (OR=11.055), pneumonia (OR=8.667), persistent fever (OR=3.836), were the independent risk factors for MODS. Conclusion The key risk factors for acute exacerbation of COPD with MODS are duration of COPD and invasive mechanical ventilation. Persistent fever also promote the occurrence of MODS.
作者 汪海涛 凌敏
出处 《海南医学》 CAS 2012年第1期6-9,共4页 Hainan Medical Journal
关键词 慢性阻塞性肺疾病 急性加重期 多器官功能衰竭 危险因素 Chronic obstructive pulmonary disease Acute exacerbation Multiple organ dysfunction syndrome Risk factors
  • 相关文献

参考文献18

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2Rabbat A.Acute exacerbation of chronic obstructive pulmonary disease[J].Rev Prat,2011,61(6):799-808.
  • 3Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101(6):1644-1655.
  • 4Hackett TB.Organ failure in critical illness[J].Vet Clin North Am Small Anim Pract,2011,41(4):9-10.
  • 5谢灿茂,周宇麒.慢性阻塞性肺疾病急性加重的诊断与治疗新进展[J].中华结核和呼吸杂志,2005,28(5):346-348. 被引量:80
  • 6Pitsiou G,Kvriazis G,Hatzizisi O,et al.Tumor necrosis factor-alpha serum levels,weight loss and tissue oxygenation in chronic obstructive pulmonary diseased[J].Kespir Med,2002,96:594-598.
  • 7Rennard SI.Chronic obstructive pulmonary disease:linking outcomes and pathobiology of disease modification[J].Proc Am Thorac Soc,2006,3(3):276-280.
  • 8Calverley PM,Anderson JA,Celli B,et al.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J].N Engl JM ed,2007,356(8):775-789.
  • 9Mannino DM,Buist AS,Petty TL,et al.Lung function and mortality in the United States:data fromthe First National Health and Nutrition Examination Survey follow up study[J].Thorax,2003,58:388-393.
  • 10Sin DD,Man SF.Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease[J].Circulation,2003,107(11):1514-1519.

二级参考文献27

  • 1Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Supp1,2003,41:46s-53s.
  • 2Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
  • 3Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.
  • 4Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
  • 5Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2) :398SM01S.
  • 6Snow V, Lascher S, Mottur-Pilson C, et al.Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med ,2001,134.595-599.
  • 7Panwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J ResDir Crlt Care Med ,2001,163:1256-1276.
  • 8Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J ,2004,23:932-946.
  • 9MacNee W. Acute exacerbations of COPD. Swiss Med Wkly,2003,133:247-257.
  • 10Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest,2000,117 (5 Suppl 2 ) :380S-385S.

共引文献5275

同被引文献161

引证文献21

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部